Net profit of Concord Drugs declined 4.35% to Rs 0.22 crore in the quarter ended December 2025 as against Rs 0.23 crore during the previous quarter ended December 2024. Sales rose 57.13% to Rs 16.97 crore in the quarter ended December 2025 as against Rs 10.80 crore during the previous quarter ended December 2024.
| Particulars | Quarter Ended | ||
| Dec. 2025 | Dec. 2024 | % Var. | |
| Sales | 16.97 | 10.80 | 57 |
| OPM % | 5.54 | 12.87 | - |
| PBDT | 0.60 | 0.90 | -33 |
| PBT | 0.30 | 0.53 | -43 |
| NP | 0.22 | 0.23 | -4 |
Powered by Capital Market - Live News